Prospective trial patients are more open to participating than investigators think

This week's Fierce Biotech is brought to you by ZS.

Trouble viewing? Click here.

 
 
Two studies highlight opportunities to improve diversity in clinical trial participants
 
Two studies highlight opportunities to improve diversity in clinical trial participants
 

Clinical trial sponsors must do a better job of ensuring prospective clinical trial patients understand What's in it for me. Personal benefits related to experience and access to care are highly motivating, according to two new ZS studies.
 

What's more, ZS found that 66% of underrepresented patients would be more comfortable participating in a trial if the investigator is a known expert in their condition.
 
 

zsinsights@zs.com
© 2022 ZS. All Rights Reserved.
One Rotary Center, 1560 Sherman Avenue, Evanston, Illinois 60201 USA +1 847 492 3600

 

If you no longer wish to receive communications from ZS, please opt out here.


Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.comor call 202-824-5074.



You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017